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Zacharia Nabil Ettaki 
DEVELOPING NOVEL METHODS TO IDENTIFY RNA-ASSOCIATED 
MECHANISMS FOR INHERITANCE 
 
 Animals depend on inheriting non-genetic information early in life to grow 
and develop naturally. This inherited, non-genetic information was previously 
thought to be limited to DNA modifications and DNA binding proteins. But recent 
studies have expanded our understanding of inheritance to include RNA and RNA 
binding proteins. We currently lack methods to identify and enrich for RNA binding 
proteins that might be involved in providing non-genetic information from mother 
to daughter cells. Others have developed a method using modified enzyme tags 
to pulse-label proteins with small molecule fluorescent ligands and follow these 
proteins as they are inherited by cells. Here I characterized and tested the 
application of a fluorescent small molecule targeting antibody to enrich for these 
labeled proteins. I first tested the ability of this antibody to bind to fluorescent 
ligand-labeled enzymes. I determined that the antibody can efficiently bind to at 
least one of the labeled enzymes. Second, I determined crystallization conditions 
for the ligand binding antibody fragment. This thesis sets the stage for structure 
determination and to test whether this antibody can work in vivo to enrich for RNA 
binding proteins involved in the delivery of non-genetic information to cells. 
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 Progeny depend on the information passed on by their parents. This 
information provides a biological program for development into an adult organism 
and protection from disease. Without proper inheritance of this information, 
developmental defects and disease run rampant. While DNA and DNA 
modifications are a primary source of inherited information, recent studies have 
determined  that RNA also plays a role (Posner et al., 2019; Vogler et al., 2018). 
My thesis aims to develop new tools to identify novel RNA-associated mechanisms 
for how animals inherit information.  
 Classically, we think of DNA, DNA modifications, and modifications to DNA  
binding proteins to be the information inherited from cell to cell and parent to child. 
These DNA and DNA binding protein modifications occur under the umbrella of 
“Epigenetics.” Epigenetics can regulate what is or is not expressed by changing 
these DNA and protein modifications without altering the underlying genetic code 
(Allis & Jenuwein, 2016). One example is the Histone Acetyltransferases (HATs). 
HATs add acetyl groups onto histones and can activate genes bound to these 
acetylated histones (Allis & Jenuwein, 2016). RNA regulatory mechanisms also 
can regulate DNA-associated epigenetics. For example, small RNAs and their 
binding proteins affect lysine histone modifications. NRDE-1, a small RNA binding 
protein, translocates to the nucleus and uses its RNA to target specific genes. A 
histone methyl transferase recruited by NRDE adds methyl groups to Histone 3 
(H3K9) to promote formation of heterochromatin (Guérin et al., 2014). Thus, 
epigenetics includes mechanisms outside of direct DNA modifications.  
 Recently, several studies have modified the concept of epigenetics to 
include RNA-mediated regulation and RNA-protein complexes. Vogler et al. looked 
at the role of ribonucleoproteins (RNPs) and how they can direct cell differentiation 
(Vogler et al., 2018). The RNA binding protein TDP-43 was found to be highly 
active during muscle repair. During simulated muscle damage, they found TDP-43 
to be in complex with mRNAs associated with muscle repair (Vogler et al., 2018). 
These TDP-43 and mRNA assemblies, dubbed “myo-granules,” were upregulated 
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during times of muscle growth and essential for cell survival. Myo-granules are 
proposed to have a significant role in cell differentiation and, when left uncleared, 
may contribute to muscle myopathies (Vogler et al., 2018). 
 In C. elegans, an RNA-protein complex plays a significant role in 
determining worm chemotaxic behavior when searching for food during stressful 
times (Posner et al., 2019). RNAi is a broad term used to encompass many 
different types of Argonaute proteins (Agos) that bind small RNAs to reduce or 
silence expression of specific mRNAs (Lodish et al., 2008). In worms, small RNAs 
with their Agos are necessary for gametogenesis and embryonic formation 
(Grishok, 2005). The RNA portion of Ago serves as a guide to identify 
complementary mRNAs and repress their expression. Posner and colleagues 
recently showed that Ago RNAs are involved in inherited behavior (Posner et al., 
2019). RDE-4, a double stranded RNA binding protein, works upstream to 
generate Ago-bound RNAs that act on the saeg-2 gene to alter worm behavior. 
Change to saeg-2 regulation occurs in response to external stimuli or internal 
nutritional states (Posner et al., 2019). These Ago small RNAs are created 
neuronally and can travel to the germline where they can repress genes, and 
subsequently the behavior of their progeny (Posner et al., 2019). In summary, new 
insights show that RNA-protein complexes play a key role in influencing cell 
development and organism behavior. These examples highlight that both RNA and 
RNA binding proteins facilitate cell or organism inheritance. I speculate that 
transmission of this inherited information must occur as RNA-protein complexes to 
preserve RNAs from degradation.  
 The biology and methods available in C. elegans make it an organism of 
choice for studying basic questions in RNA biology. The nematode is translucent 
to allow easy visualization of its cells, requires modest resources to live, and has 
a short generational time to study inheritance questions. Furthermore, new 
methods in molecular genetics enable genes to co-express robust protein tags 
(Juillerat et al., 2003; Los et al., 2008). Single gene editing is the process of 
inserting or altering a gene at its authentic locus. We can currently perform single 
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gene editing in C. elegans through Mos1 transposon-mediated modification or 
sequence-specific CRISPR/Cas9 (Nance & Frøkjær-Jensen, 2019). So, molecular 
methods are available to manipulate the C. elegans genome to express tags useful 
for imaging and tracking of protein components. 
 Two fusion protein tags that can be expressed in C. elegans  are Snap and 
Halo. Both fusion proteins are optimal tools for protein labeling and cell imaging. 
Halo is derived from a bacterial haloalkane dehalogenase enzyme that reacts with 
haloalkane derivatives (Figure 1A) (Los et al., 2008), and  SNAP is a modified 
alkylguanine-DNA transferase that reacts with benzylguanine (BG) derivatives 
(Figure 1C) (Juillerat et al., 2003). Mutations in both enzyme active sites trap 
substrates as covalent intermediates (Figure 1B and 1D) (Juillerat et al., 2003; Los 
et al., 2008), preventing ligand dissociation. Synthetic commercial ligands with 
substrates attached to fluorescent molecules (e.g. tetramethylrhodamine, TMR) 
can substitute for its normal substrates, allowing labeling of tagged proteins. These 
tags can be expressed with a protein of interest. 
 Others have used the SNAP and Halo tags to specifically label proteins and 
follow their stability in organisms over time. One group looked at how dynamic 
chromatin organization interacts with specific histone variants (H3.1 and H3.3) by 
using siRNA to knockdown expression of the histone chaperone CAF-1 and SNAP 
labelling the histone chaperone HIRA to visualize its specific function (Clément et 
al., 2016). Another group looked at how SNAP labelling could be a method to 
measure biological functions by measuring the half-life of various extra- and intra-
cellular proteins (Bojkowska et al., 2011). Additionally, they demonstrated that in 
vivo SNAP-labelled tumors could be visualized using near-infrared probes. Finally, 
a pulse-chase assay was used with a SNAP-tagged H3 histone variant (Jansen et 
al., 2007), centromere protein A (CENP-A). CENP-A helps form centromere 
chromatin and subsequently its exit from mitosis. In both of these studies, ligands 
were pulsed in cells or animals, showing that enzyme-labelled proteins can be 
visualized and studied for their stability and movement within cells or animals. Halo 
protein has also been shown to be an effective tool to study protein stability and 
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cellular dynamics. One group looked at the role of proprotein convertase subtilisin-
like kexin type 9 (PCSK9) in both intracellular and extracellular locations by pulsing 
with a cell impermeable and cell permeable fluorophores to visualize the functions 
on the inside and outside of the cell, respectively (Fischer, 2013). Li and colleagues 
were able to use Halo to study the dynamics of secretory granules through a Zinc 
fluorescent indicator (Li et al., 2015). Historically, green fluorescent protein (GFP) 
is the gold standard for protein imaging (Dunst & Tomancak, 2019)(Lavis & Raines, 
2008). While GFP can be an optimal tag for protein visualization, it does not have 
multiple functionalities like SNAP or Halo.  GFP also cannot be pulse labeled 
through chemical modification as described for SNAP or Halo in previous 
examples. In short, the SNAP and Halo tags provide a fantastic tool for fluorescent 
imaging and protein dynamics in cells and organisms like C. elegans.  
 Imaging and following proteins of interest in vivo with SNAP or Halo requires 
the use of a fluorescent small molecule. Small molecule fluorescence is defined as 
the emission of a photon upon excitation of a fluorophore (reviewed in (Dunst & 
Tomancak, 2019) and (Lavis & Raines, 2008)). The absorption of photons excites 
the fluorophore from its ground state (Figure 2A). The photon returning to its 
ground state causes a fluorescence signal (Figure 2A). The extinction coefficient 
is the probability that a fluorophore will absorb a photon. Fluorophores with high 
extinction coefficients are brighter than ones with low extinction coefficients and 
tend to be useful when light intensity needs to be kept to a minimum, such as when 
imaging living tissues or when there are very few fluorophore molecules (Lichtman 
& Conchello, 2005). Quantum yield is the ratio of fluorescence emission to 
nonradiative energy losses (Lichtman & Conchello, 2005). It is a direct measure of 
the efficiency of turning absorbed light into emitted light (Christian et al., 2013). For 
example, TMR, a derivative of xanthene dyes, has a quantum yield of 0.68 in 
aqueous solutions and has an emission of around 550 nM (Lavis & Raines, 2008). 
This lower quantum yield is likely due to the decay of the excited state around the 
rotation of the aromatic ring on TMR (Figure 2B). Preventing this ring from rotating 
can either promote or inhibit fluorescence, dependent on the ring position (Figure 
2B). Studies with Fluorescein, a fluorescent molecule with a similar chemical 
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structure to TMR, have shown that maintaining the fluorophore in a certain position 
can quench fluorescence (Gayda et al., 2016). Increasing fluorophore rigidity in a 
specific position can come from the internal chemical structure (Lavis & Raines, 
2008) or externally through fluorophore binding proteins, like antibodies. 
 Small molecule fluorescence can be used to visualize movement and effect 
of RNA-proteins complexes in vivo. Using a fluorescent fluorophore, such as TMR, 
we can tag and visualize RNA-protein complexes (Figure 3). This method allows 
for easy visualization of the movement of those RNA-protein complexes, but to 
study and characterize the RNA within the complex we need to enrich and isolate 
them. This can be done with antibodies (Figure 3). Using an antibody to specifically 
bind and pulldown complexes is called immunoprecipitation and has been used as 
a reliable and effective way to isolate and purify proteins of interest (Verhelst et al., 
2015). 
 Antibodies are critical biological tools. They have a wide range of uses from 
isolating proteins out of solution, to modifying small molecule fluorescence. In 
biology, they are central to the adaptive immune system. In research, they are also 
important markers and reagents used for studying the identification and labeling of 
biological molecules. There are five classes of antibodies: IgA, IgM, IgG, IgD, and 
IgE. Each class plays a different role in the body in how and when they are 
expressed and how they work against disease. IgG is the predominant isotype 
found in the body and is made up of a light chain (~25 kDa) and heavy chain (~50 
kDa) (Figure 4) (Adhikary et al., 2019). The general shape of IgG resembles the 
letter ‘Y’. The bottom base of that ‘Y’ is called the Fc (Fragment constant) domain, 
while the two arms comprise the Fab (Fragment antigen binding) domain. IgG is 
comprised of four subclasses (IgG1-IgG4). IgG1 and IgG3 are both induced in 
response to protein antigens. IgG2 and IgG4 are associated with polysaccharide 
antigens (Schroeder & Cavacini, 2010). The four subclasses differ on the number 
of disulfide bonds they have. Disulfide bonds are formed between two cysteine 
residues in oxidizing conditions. They are what connects the light and heavy chains 
to each other (Figure 4). Disulfide bonds are broken by reducing agents. Partial 
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reduction of the disulfide bonds specifically at the hinge region connecting the CH2 
domains causes an increased flexibility of the hinge and increased susceptibility 
to proteases (Schroeder & Cavacini, 2010). The Fc domain is primarily involved in 
binding to effector cells or activating other immune mediators such as complement 
(Schroeder & Cavacini, 2010). This Fc portion is how we define the isotype and 
subclass of the immunoglobin (Schroeder & Cavacini, 2010). 
 The Fab domain specifically recognizes target molecules. The Fab contact 
surfaces are comprised of six complementary determining regions (CDR) or loops, 
three from the heavy chain and three from the light chain (Adhikary et al., 2019). 
Of these six loops, the heavy chain 3 (H3) loop is by far the most variable in length, 
sequence, and structure. CDR H3 can range between 1-35 amino acids in length. 
It can be almost 40% of the length of the Fab body itself (Adhikary et al., 2019). 
CDRs H3, H2, and L3 (light chain 3) make the largest contribution to interfacing 
with the antigen. L2 is notable for making the smallest and sometimes no 
contribution to the interface (Adhikary et al., 2019). A major research focus is 
understanding how antibodies recognize their target antigen. Structural biology 
has played a major role in this effort through determination of crystal structures of 
Fabs bound to their antigen targets.  These structures show us to atomic resolution 
how antibody CDR loop amino acids interact with their antigens. In the case of 
fluorophore-binding antibodies, structures of fluorophore-antibody complexes will 
inform us how these antibodies change the conformation of the fluorophore to 
increase or decrease its fluorescence. 
 Much of our understanding how antibodies change fluorophore spectral 
properties come from work using Fluorescein-binding antibodies. Early studies 
showed how these antibodies can bind to their fluorophore targets (Bedzyk, 
Herron, et al., 1990; Bedzyk, Weidner, et al., 1990). Additionally, studying how 
antibodies bind to fluorescent ligands can give insight into how we can improve 
antibody binding interactions to small molecules. One such group studied 
fluorescein fluorescence quenching when bound to mAb 4-4-20 and found that 
increasing rigidity and decreased solvent accessibility improved quenching 
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(Swindlehurst & Voss, 1991). Another group determined crystal structures of Fabs 
bound to fluorescein (Bedzyk, Weidner, et al., 1990; Gayda et al., 2016). Their 
work showed that quenching is likely due to the antibody preventing planar rotation 
of the fluorophore’s carboxyphenyl moiety (Figure 2B). Preventing rotation around 
this carboxyphenyl chemically has also been shown to quench fluorescence (Lavis 
& Raines, 2008). Of note, directed evolution of an antibody identified antibody 
mutations with an 1800-fold increase in binding affinity towards fluorescein 
(Midelfort, 2006). Crystal structures showed that mutations at the edge of the 
binding site lessened the negative charge repulsion between fluorescein and the 
antibody (Midelfort, 2006), presumably increasing binding affinity. Antibody-
fluorescein binding was studied and it was found that in general, Tryptophan and 
Tyrosine residues are required for general binding in the active site of the antibody.  
Other residues (e.g. Serine, Histidine, Arginine, and Asparagine) are used for fine-
tuning and binding specificity (Denzin et al., 1991). Recently, antibodies were 
identified to bind rhodamine (Eisold et al., 2015), a TMR relative. These antibodies 
are reported to enhance or quench fluorescence. I predict that the rhodamine-
quenching antibody restricts planar rotation of rhodamine derivatives, similar to the 
fluorescein-quenching antibodies. There are no published structures of antibodies 
that enhance fluorophore binding, but I predict that a rhodamine-enhancing 
antibody promotes a planar conformation of the fluorophore. Additionally, 
structural characterization of these rhodamine antibodies should allow structure-
based design of antibody mutations that enhance rhodamine affinity. 
 My research focuses on developing new molecular tools to identify 
information associated with RNA-protein complexes. Recently, others in the lab 
have been using Halo- and SNAP-tagged RNA binding proteins and TMR ligands 
to label and follow these proteins during cell development. The long-term vision is 
to be able to use molecular reagents like antibodies to enrich for these TMR-
labeled RNA-protein complexes to determine their RNA targets (Figure 3). As 
discussed previously, others have identified antibodies that bind rhodamine (Eisold 
et al., 2015), a TMR relative.  Thus, if we are able to use rhodamine-related ligands 
to label proteins, we can potentially use rhodamine-binding antibodies to enrich for 
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these complexes (Figure 3). My work determined the usefulness of a rhodamine-
binding antibody for imaging and immunoprecipitation of TMR-labeled proteins. 
First, I used pull-down assays to determine whether this antibody can enrich for 
TMR-labeled Halo or SNAP tags. Second, I attempt to use x-ray crystallography 
to determine how this antibody binds to rhodamine. The structure will inform us 
how the antibody recognizes this small molecule and affects its fluorescence. 
Based on my results, we conclude that the antibody can be used to enrich for TMR-
bound Halo but not SNAP. I identified preliminary conditions to crystallize a 
rhodamine binding Fab.  Additional optimization will be needed for usable crystals 
for structure determination. Regardless, my work sets the stage to use this 





Halo recombinant protein purification 
 His-tagged SNAP recombinant protein was a gift from Judith Kimble (Figure 
5A). Halo protein was purified from recombinant sources. Briefly, a pET21a(+) 
vector expressing a his-tagged Halo (pDDC40) was transformed into BL21 E. coli 
(Thermo Scientific) and selected by Ampicillin. Transformed bacteria were cultured 
in LB broth (1% (bacto)-tryptone, 0.5% yeast extract, 1% NaCl) at 37oC, 225 rpm 
until the A600 Optical Density was between 0.4 - 0.8, as detected with an Ultrospec 
3100 pro spectrophotometer (GE Amersham Biosciences). Bacteria were induced 
with 0.1 mM Isopropyl β- d-1-thiogalactopyranosid (IPTG), cultured at 16oC and 
160 rpm, and collected after 16-18 hours incubation. Samples were collected, 
centrifuged at 5500xg for 10’ and 3200xg for 30 minutes at 4oC, and frozen in liquid 
nitrogen. The bacterial pellet was stored at -80o C until use.  
 For purification, pellets were thawed on ice and resuspended in HN300 
buffer (20 mM HEPES pH 7.0, 300 mM NaCl) supplemented with 10 mM imidazole. 
Cells were lysed using a microfluidizer (Divtech Equipment Co.) on ice. Samples 
were centrifuged at 3200xg for 30 minutes at 4oC, and the supernatant incubated 
with nickel-NTA agarose beads (HisPur Ni-NTA Resin, Thermo Scientific). The 
slurry was added to a gravity column and washed with HN300 buffer supplemented 
with increasing concentrations (10 mM, 20 mM, and 40 mM) of imidazole. Proteins 
were then eluted off beads with HN300 buffer supplemented with higher 
concentrations of imidazole (60 mM, 80 mM, 100 mM, and 250 mM). The 60-250 
mM imidazole fractions were run on SDS-PAGE to confirm presence of Halo 
protein and to visualize the relative purity of each fraction. Fractions were then 
dialyzed with a 3K MWCO dialysis membrane (Spectra/Por) in HN buffer (20 mM 
HEPES pH 7.0, 100 mM NaCl) overnight at 4oC,  concentrated (Vivaspin Turbo 4, 
Sartorius), and purified by size exclusion chromatography (SEC) with an Enrich 
SEC 650 column (Bio Rad, 24 mL capacity, separation range of 5 kDa – 650 kDa) 
using an NGC FPLC Chromatography System (Biorad) (Figure 5B). SEC fractions 
were deposited in 0.5 mL portions. Fractions were analyzed by SDS-PAGE and 
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Coomassie staining (Figure 5C). Halo eluted at the approximate position expected 
for a 36 kDa protein based on previously run protein standards (Bio Rad). Those 
fractions with the most recombinant protein and least background were 
concentrated and used for experiments. Halo and SNAP were quantified by A280 
absorbance using the NanoDrop 1000 spectrophotometer (Thermo Scientific). The 
proteins used are shown by SDS-PAGE and Coomassie staining on Figure 5A. 
Immunoprecipitation 
 Purified SNAP or Halo recombinant protein were incubated with TMR ligand 
(Halo-TMR (Promega), SNAP-TMR (NEB)) at 4oC for 1 hour in PBS-T (1x PBS 
with 0.01% tween-20)(Figure 6). G71-DC7F5 IgG antibody (In Vivo; Eisold et al., 
2015) was incubated with Protein G Sepharose beads (GE Healthcare) for 1 hour 
in PBS-T at 4oC (Figure 6). The antibody-bead and protein-ligand mixtures were 
then mixed together in Pierce Micro-Spin columns (Thermo Scientific) and 
incubated overnight at 4oC (Figure 6). Using the spin column, samples were then 
washed 6 times with PBS-T prior to elution from the beads using 2X SDS-PAGE 
sample buffer (Bio Rad) supplemented with β-mercaptoethanol (Acros Organics). 
Samples were analyzed by immunoblot (see below).  
Immunoblot 
 Samples were run on SDS-PAGE gels, and proteins were transferred to 
polyvinylidene difluoride (PVDF) membranes using Transblot Turbo transfer packs 
(Bio Rad) in a Transblot Turbo Transfer System (Bio Rad). PVDF membranes were 
then blocked with 5% evaporated milk in PBS-T followed by overnight incubation 
in 5% evaporated milk PBS-T with anti-histidine antibody (Novus) at 4oC. The 
following day, the immunoblot was washed with PBS-T and incubated for 45 
minutes in 5% evaporated milk PBS-T with horseradish peroxidase secondary 
antibody (R&D Systems Bio-techne) at 20oC. Membranes were washed again with 
PBS-T and developed using Luminal/Enhancer SuperSignal West Femto and 
SuperSignal West Pico chemiluminescence (Thermo Scientific). The developed 
membrane was imaged on a ChemiDoc MP imaging system (Bio Rad). 
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Fab generation and purification 
 The method and reagents to generate Fabs were from the Pierce Fab 
Preparation Kit (Thermo Scientific). To test antibody cleavage conditions by 
papain, hybridoma-derived G71-DC7F5 IgG antibody (In Vivo, Eisold et al., 2015) 
was incubated with cysteine-supplemented Digestion Buffer (Thermo Scientific) 
and agarose-immobilized papain (Thermo Scientific) at 37⁰C. Samples were 
collected over time and stored in 2x SDS-PAGE sample buffer (250 mM Tris pH 
6.8, 25 mM EDTA pH 8.0, 25% glycerol, 5% SDS) at -20⁰C prior to analysis by 
Coomassie-stained SDS-PAGE. Gels were imaged with a ChemiDoc MP imaging 
system (Bio Rad). 
 For larger scale Fab purification, antibody was incubated with the digestion 
conditions determined previously, and the sample was purified with a Protein A 
column (Thermo Scientific) and Size Exclusion Chromatography (Enrich SEC 650, 
Bio Rad). Chromatography fractions were analyzed by SDS-PAGE. Those 
fractions primarily with Fab were collected, concentrated (3K MWCO, Sartorius), 
and used for structural studies. 
Crystallization 
 Purified Fab (5 mg/ml) was screened for crystallization conditions using in-
house grid and commercial sparse matrix crystal screens. The in-house grid 
screens varied pH (5-9), and different concentrations of Polyethylene glycol (PEG), 
salt (Sodium Citrate, Lithium Sulfate, Magnesium Sulfate, Ammonium Sulfate, and 
Sodium Malonate) and 2-methyl-2,4-pentanediol (MPD). We tried two commercial 
sparse matrix screens: JCSG+ (Nextal) and Natrix (Hampton Research). Screens 
were set up in 96 well, sitting drop trays using an Oryx4 (Douglas Instruments). 
Crystals were observed after two weeks in 0.2 M Lithium Sulfate, 0.1 M Tris pH 
8.5, 40% (v/v) PEG 400. Crystals were rod-like and less than 20 microns in length. 





Rhodamine antibody immunoprecipitation of TMR-labeled SNAP and Halo 
proteins 
 The goal was to develop a method to isolate TMR-labeled SNAP and Halo 
proteins (Figure 4). Others have used SNAP and Halo protein tags as tools to pulse 
label proteins in cell culture and track their stability over time (Bojkowska et al., 
2011; Los et al., 2008). A method to specifically isolate older, labeled RNA binding 
proteins versus newly made, unlabeled protein would allow us to identify 
differences in their target RNAs (Figure 4). 
 Antibody G71-DC7F5 IgG (G71 IgG) specifically binds to rhodamine (Eisold 
et al., 2015). We speculated it could also bind to tetramethylrhodamine (TMR), a 
chemical relative of rhodamine and commercially available as a ligand for both 
SNAP and Halo. To test whether G71 IgG could bind to TMR-labeled SNAP or 
Halo recombinant proteins, we performed immunoprecipitation assays. For the 
assays, we used SNAP and Halo recombinant protein purified from bacteria 
(Figure 7 and Figure 8). Both proteins were labeled with TMR ligand, then 
immunoprecipitated with G71 IgG bound to Protein G Sepharose beads. For 
controls, I excluded TMR ligand or G71 IgG in parallel samples to show that 
immunoprecipitation was dependent on the presence of both TMR and antibody  
(Figure 7 and Figure 8). Samples were bound to the beads and washed extensively 
before elution and analysis by SDS-PAGE immunoblot (Figure 6). The last wash 
sample was also analyzed to demonstrate that the elution sample only included 
protein bound to the beads. An anti-his tag antibody was used to detect 
recombinant SNAP and Halo proteins. The secondary antibody also detected G71 
IgG, labeling the heavy and light antibody chains (Figure 7 and Figure 8).  
 TMR-labeled SNAP protein did not immunoprecipitate (Figure 7). Labeled 
SNAP protein was incubated with G71 IgG and Protein G Sepharose beads and 
tested for immunoprecipitation. SNAP was not detected in the elution, but the 
antibody bound well to the beads (Figure 7). I tried several rounds of this 
immunoprecipitation experiment, varying temperature, order of addition, and time. 
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In the discussion below, I discuss potential reasons why SNAP protein did not 
immunoprecipitate and how we could improve the assay. I currently conclude that 
the SNAP is not amenable for immunoprecipitation with G71 IgG. 
 TMR-labeled Halo protein did immunoprecipitate (Figure 8). The 
immunoprecipitation assay was performed similarly to SNAP immunoprecipitation 
but worked on the first trial. TMR-labeled Halo protein was incubated with G71 IgG 
and Protein G Sepharose beads and again tested for immunoprecipitation. This 
time, both Halo and antibody were detected in the elution (Figure 8). Three distinct 
bands were in the elute lane. Two of these bands corresponded with light and 
heavy chain antibody, while the third band corresponded to Halo protein (Figure 
8). Halo immunoprecipitation was not observed in the absence of TMR ligand or 
G71 IgG, as expected. Controls for Halo were the same as SNAP, I excluded TMR 
or antibody to determine if the immunoprecipitation was dependent on both of 
those elements. Varying the Halo/ligand and the antibody/Protein G bead binding 
time had little effect on immunoprecipitation. I discuss below the attributes of Halo 
that may allow G71 IgG immunoprecipitation versus SNAP. Regardless, I conclude 
the G71 IgG can be used to enrich for TMR-labeled Halo proteins. 
 
Crystallization of a rhodamine-binding Fab 
 I sought to determine the crystal structure of G71 Fab bound to its 
rhodamine ligand to understand how the antibody interacts with the fluorophore 
and why G71 quenches fluorophore fluorescence (Eisold et al., 2015). Previous 
structural work of an antibody that quenched fluorescein, another chemical 
fluorophore, identified that the antibody locked a phenyl ring in a position that 
blocked fluorescence (Denzin et al., 1991; Gayda et al., 2016). I speculate that 
G71 works similarly with rhodamine and its chemical relatives. The structure will 




G71 Fab was optimized and purified under standard procedures (see Methods). 
Papain cleaves IgG into antigen binding (Fab) and structural (Fc) fragments. I 
optimized IgG cleavage with papain (Figure 9A) and used these conditions to 
generate Fab fragments for structure determination. A Protein A or G column was 
used to remove contaminating post-cleavage antibody Fc fragment, and size 
exclusion chromatography used as a final purification step (Figure 9B-C). Purified 
G71 Fab was used in crystallization trials using in-house grid and commercial 
sparse-matrix screens. After two weeks, small 3-dimensional, rod-like crystals, 
less than 20 microns in length, were observed by light microscopy (Figure 10). We 
are currently following up this crystallization hit by varying the salt and precipitant 
concentrations. I discuss below additional ideas to obtain diffraction quality crystals 






 The focus of this thesis was to develop new methods to identify labeled 
RNA-protein complexes with the long-term goal of enriching for these complexes 
and identifying their associated RNA information. I approached this problem from 
two different angles. One was to test whether a rhodamine antibody, G71 IgG, 
could bind and enrich protein tags labeled with a rhodamine derivative. The other 
was to determine the structure of the rhodamine antibody bound to its ligand. I 
made progress in both approaches, and we are now poised to test the usefulness 
of this antibody for RNA-protein complex enrichment in biological samples. 
 My work determined that G71 IgG could be used to immunoprecipitate 
TMR-labeled Halo. I did not observe enrichment of TMR-labeled SNAP. This 
discrepancy may be due to several reasons. First, Halo exhibited a much stronger 
input signal than SNAP, implying that more Halo protein was used in the binding 
reactions.  Further work should consider trying several different concentrations of 
Halo and SNAP to quantitatively estimate immunoprecipitation efficiency. Second, 
Halo binds to its ligand (TMR) better than SNAP (Halo, 2700000 M-1 s-1 (Los et al., 
2008); SNAP, 6000 M-1 s-1 (Juillerat et al., 2003)). Better binding increases the 
chances of antibody binding to TMR-labeled protein. Last, Halo or SNAP binding 
to its ligand may change the shape or accessibility of TMR to the antibody. This 
could prevent the antibody from recognizing the ligand and prohibit 
immunoprecipitation. Regardless, my results suggest that Halo should be used as 
the fusion protein of choice for G71 IgG immunoprecipitation-related experiments. 
 The next logical step for immunoprecipitation is to move from in vitro to in 
vivo. G71 IgG enriched for TMR-ligand bound recombinant Halo protein. I suggest 
testing enrichment of Halo tagged proteins in cell culture or animals. Prior work 
demonstrated that similar enzyme tags could be used to label proteins and track 
their stability over time ((Hoelzel & Zhang, 2020; Li et al., 2015; Los et al., 2008).  
G71 IgG allows us to now enrich for these stable, labeled proteins to see if their 
protein binding partners or bound nucleic acid targets change over time. In the 
case of RNA-protein complexes, we may be able to use this labeling strategy and 
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immunoprecipitation to further our understanding of how RNA-protein complexes 
shape organism development.  
 I attempted to determine the structure of the G71 Fab antigen binding 
fragment in complex with rhodamine.  This effort lead to identification of a condition 
that formed small rod crystals of G71 Fab. These crystals are approximately less 
than 20 microns in length and most likely too small for structure determination. 
Further work should focus on optimizing the conditions to enlarge crystal size.    
Some ways to grow larger crystals include condition optimization and 
microseeding. Condition optimization refers to changing different elements in the 
conditions in which initial crystals were grown in. By slightly altering the pH, salt 
concentration, or precipitant concentration, we may be able to produce larger, 
higher quality crystals. Another method to grow larger crystals is microseeding 
(Oswald et al., 2008). Crystal formation requires first nucleation and then crystal 
growth. Microseeding provides nucleation to the crystal growth condition. By 
placing an already nucleated “seed” into solution, crystals now only need to grow. 
Crystal grew after two weeks. Crystal growth can be impacted by time required to 
form a crystal lattice or protein purity impeding nucleation and growth. Future 
efforts should work to improve protein purity. 
 The structure of G71 Fab bound to rhodamine will provide two key pieces 
of information. It will show us how this Fab binds to a small molecule. By 
understanding the binding structure of the antibody to its ligand, we may be able 
to improve its binding affinity through rational mutagenesis. Mutagenesis has been 
utilized to improve antibody-fluorescent ligand binding. One group used 
fluorescein-binding antibody 4-4-20 and site directed mutagenesis to increase 
antibody binding to fluorescein by 1800-fold (Midelfort, 2006). The crystal structure 
will also inform us why G71 quenches rhodamine fluorescence (Eisold et al., 
2015). Previous structural work with fluorescein antibodies determined that the 
fluorophore is locked in a conformation that prevents fluorescence (Bedzyk, 
Herron, et al., 1990; Denzin et al., 1991).  I predict that G71 also locks rhodamine 
and rhodamine derivatives in a similar conformation. Mutagenesis can be used to 
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test any fluorescence quenching model.  Future work should also focus on 
determining the crystal structure of a different rhodamine antibody that enhances 
fluorescence (Eisold et al., 2015). Structural work is not available of antibodies that 
enhance fluorescein fluorescence. These two rhodamine structures will thus give 
us novel insight into how antibodies are capable of affecting small molecule 
fluorescent properties. Since locking the fluorescein carboxyphenyl group 
perpendicular to the xanthene moiety prevents fluorescence (Gayda et al., 2016), 
I predict that locking the carboxyphenyl group planar to the xanthene moiety will 
promote fluorescence. Additionally, having two antibody tools at our disposal may 
help in our efforts to enrich for labeled RNA-protein complexes. 
 The long-term goal is to develop methods that may be used to study the 
information delivered by RNA-protein complexes. As I discussed in the 
introduction, the term epigenetics now includes RNA-protein complexes that are 
passed from cell to cell, and even in some cases mother to progeny. How do these 
complexes shape an organism? Why are these complexes utilized? How important 
are they to organism development and survival? Answering these questions 
requires development of novel methods, like those investigated in this thesis, to 
isolate these RNA-protein complexes and push our understanding of inheritance 





Figure 1. Crystal structures of SNAP and Halo bound to their ligands. (A) Crystal 
structure of Halo bound to its benzoxadiazole ligand (red). Modified from Kang and 
colleagues (PDB ID: 5Y2Y, Kang et al., 2017). (B) Molecular details of the Halo 
binding pocket interacting with the benzoxadiazole ligand (red). Interacting amino 
acid side chains forming hydrogen bonds and salt bridges are highlighted in yellow. 
(C) Crystal structure of SNAP bound to its benzyl guanine ligand (red). Modified 
from Schmitt and colleagues (PDB ID: 3KZZ). (D) SNAP-ligand amino acid side 






Figure 2. Chemistry of TMR fluorescence. (A) Fluorescence emission and 
excitation diagram. Through the absorbance of a specific wavelength of light 
(green arrow), the fluorophore increases its energy from its ground state to an 
excited state. At this point, internal conversion may occur. This is the act in which 
a higher vibrational energy is achieved while the molecule itself shifts to a lower 
electronic state. Fluorescence is achieved when shifting from the excited state 
back down to the ground state. As this happens, photons are emitted. Because of 
the release of some energy during internal conversion (small red arrow), the 
emitted light is released at a longer wavelength (less energy, yellow arrow). (B) 
Chemical structure of tetramethylrhodamine (TMR). Rotation of the benzyl ring 





Figure 3. Enrichment of RNP complexes using Halo or SNAP fusion proteins. 
SNAP or Halo can be expressed with an RNA binding protein of interest. This 
permits labelling of the tags with a rhodamine derivative ligand (1). Using a 
rhodamine-binding antibody, TMR-bound RNA-protein complexes can be enriched 
from unlabeled complexes (2-3). Enriched samples can then be sequenced to 





Figure 4. Antibody diagram. Fab and Fc portions labeled. Papain cleaves along 






Figure 5. Halo protein purification. (A) SDS-PAGE gel showing expression of both 
SNAP “S” and Halo “H” fusion proteins next to protein ladder “L” measured in 
kilodaltons “kDa”. (B) Halo Chromatogram following SEC purification on FPLC. 
Fractions 23-34 were considered to have the most Halo protein and were run on 
SDS-PAGE to assess relative purity. (C) SDS-PAGE gel run with fractions from 






Figure 6. Schematic of the immunoprecipitation protocol. Fusion protein/TMR  and 
beads/antibody pairs were incubated for an hour at 4oC. Both mixtures were 
combined and incubated overnight before being washed and eluted. Protein was 





Figure 7. Immunoblot of a failed SNAP immunoprecipitation with a rhodamine-
binding antibody. No SNAP band is visible in the elute. While SNAP protein was 
not found in the elute, antibody binds well to the beads. Antibody heavy and light 
chain are labeled alongside SNAP protein, which runs at just under light chain 
antibody. L, ladder; kDa, kilodaltons; i, initial unwashed sample; W, washed 







Figure 8. Immunoblot of Halo immunoprecipitation with a rhodamine-binding 
antibody. Each IP was washed before eluting with 2x SDS-Sample buffer. Controls 
determined if IP was dependent on either antibody or TMR by leaving one or the 
other out of the experiment. IP was depended on both antibody and TMR. Heavy 
and light chain antibody are labeled along with Halo protein, which runs between 
antibody bands. L, ladder; kDa, kilodaltons; i, initial unwashed sample; W, washed 






Figure 9. Rhodamine antibody cleavage and Fab purification. (A) Coomassie-
stained SDS-PAGE gel of antibody cleavage time course with papain. Antibody 
was incubated with immobilized Papain resin and samples were collected over 
time. 50 kilodalton (kDa) bands represent uncleaved heavy chain and 25 kDa 
bands are light chain and cleaved Fab heavy chain fragments. h, hours. (B) Size 
exclusion chromatography (SEC) of papain-cleaved antibody. Protein was 
detected by UV absorption (A280). Fractions in the red box were analyzed by SDS-
PAGE and Coomassie-staining. (C) Coomassie-stained SDS-PAGE gel of size 
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exclusion fractions. Numbered fractions correspond to chromatogram in (B). (+), 
sample after cleavage. B, blank gel lane. kDa, kilodaltons. Fractions 15-20 (red 













Figure 10. Crystals of a rhodamine-binding Fab. Crystals are rod-like and less 
than 20 microns in length. Circled in red is a large formation of several crystals. 
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